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Abstract
Cranial window implants in head-fixed rodents are becoming a preparation of choice for stable 
optical access to large areas of cortex over extended periods of time. Here, we provide a highly 
detailed and reliable surgical protocol for a cranial window implantation procedure for chronic 
widefield and cellular imaging in awake, head-fixed mice, which enables subsequent window 
removal and replacement in the weeks and months following the initial craniotomy. This protocol 
has facilitated awake, chronic imaging in adolescent as well as adult mice over several months 
from a large number of cortical brain regions; targeted virus and tracer injections from data 
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obtained using prior awake functional mapping; and functionally-targeted two-photon imaging 
across all cortical layers in awake mice using a microprism attachment to the cranial window. 
Collectively, these procedures extend the reach of chronic imaging of cortical function and 
dysfunction in behaving animals.
INTRODUCTION
The current generation of optical imaging and optogenetic tools provide unprecedented brain 
access for selectively mapping and manipulating various microcircuit elements across 
cortical brain regions. As a result, these methods are growing in popularity for studying the 
relationship between neuronal activity and behavior in awake, behaving mice. However, it 
can often be difficult to focus light onto the mouse brain through the skull and collect high-
resolution two-photon images over long periods of time (weeks to months), due to light 
scattering caused by skull irregularities or regrowth1–3. Additionally, skull thinning methods 
can be limited to a small number of imaging sessions due to requirements for repeated skin 
closing and resection4. Consequently, glass cranial windows are currently the method of 
choice for studying the activity of neuronal populations over extended periods of time5–8 
(but see ref. 9). Yet, the existence of standardized, detailed and versatile surgical protocols 
for chronic window implants geared to functional imaging in awake mice are scarce. In 
particular, it remains challenging to combine imaging with multiple procedures that require 
intermittent access to the brain
Previous cranial window implant methods have offered useful strategies for reducing brain 
motion during long-term imaging in anesthetized6 or awake5 mice, by applying a viscous 
substance between the brain and the coverglass to increase adhesion and/or pressure 
(agarose6 or Quick Sil5). While effective, these methods make it difficult to subsequently 
remove and replace the cranial window without damaging the brain. The modified cranial 
window implant approach that we describe here enables the removal and replacement of the 
cranial window. This approach facilitated our previous chronic two-photon imaging studies 
in awake, adult mice13–15, for the following reasons. First, window implant prior to 
subsequent removal for viral injection initially enabled high-resolution intrinsic 
autofluorescence mapping of multiple visual areas in awake mice (providing high-resolution 
multi-areal maps with strong activation of higher visual areas). Following functional 
mapping, removal of the window was critical for targeting viral infection13–15 of a 
genetically encoded calcium indicator (AAV2/1-GCaMP3) to a focal region within a small 
visual cortical area (e.g. GCaMP3 expression extending <300 μm within the borders of 
lateromedial cortical area LM, see ref. 15; see also Anticipated Results). Second, removal of 
the cranial window at or after the time of viral injection allowed removal of skull regrowth 
and/or thickened dura, thus providing enhanced clarity while extending the lifetime of 
imaging through the window. Third, removal of the cranial window enabled replacement 
with an assembly consisting of a 1 mm microprism coupled to a replacement cranial window 
at a precise location and orientation. This method facilitated functionally-targeted two-
photon calcium imaging across all cortical layers, simultaneously, in awake mice. While 
cranial window removal and replacement has not been commonly used by other labs during 
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chronic cortical imaging in awake mice, similar procedures are routinely used and highly 
valuable for chronic cortical imaging studies in primates17.
Here, we provide detailed protocols developed and standardized in our labs for a set of 
related procedures to achieve long-term cortical imaging, together with interspersed and 
repeated surgical access to the brain. A flowchart of these surgical procedures and their 
estimated durations is provided in Fig. 1. These procedures have evolved to maximize 
experimental flexibility, consistency across surgeons, and imaging success rates.
Comparison with previous cranial window protocols
A critical first step for all procedures described above involves the initial chronic implant of 
a large (5 mm) cranial window, which we have used in previous studies for imaging the 
posterior cortex of anesthetized10,11 or awake12–15 adult mice across several days to months, 
and for extending the reach of chronic imaging in awake mice to earlier ages overlapping the 
visual critical period16 (Fig. 2). This window implant procedure (PROCEDURE Steps 1-78 
of the protocol) has some similarities to previous methods4-8, but differs in several key 
aspects:
• As discussed above, our initial window implant (PROCEDURE Steps 60-75) 
combines the previous ability to achieve high brain stability during awake imaging5 
with the capacity for subsequent removal and replacement of the cranial window.
• In our experience, moving the mouse to headpost clamps (PROCEDURE Steps 
32-37; as opposed to using earbars throughout the surgery) is extremely useful for 
precise drilling and for decreasing the risk of brain insult during the craniotomy 
(PROCEDURE Steps 49-59), as the head is more stable than when drilling while 
the head is held with earbars. It is also our subjective impression that this approach 
improves visibility during surgery as the skull has been rotated such that the entire 
craniotomized region remains in focus. This also facilitates subsequent functional 
imaging by ensuring that the cranial window is always roughly co-planar with the 
headpost.
• The protocol describes how to effectively combine the large headpost/window 
surgery with electroencephalography (EEG) recordings12 (PROCEDURE Steps 
32-37).
• Several early steps in this initial implant procedure contain extensive detail that we 
feel have increased our likelihood of maintaining long-term sterility (e.g. 
PROCEDURE Steps 19-27) and stability (PROCEDURE Steps 30, 38-40) during 
chronic awake imaging, and have minimized the risk of intra-surgical fatalities 
(PROCEDURE Steps 1-18, 76-78).
We then describe the procedure we have used for repeated removal of the cranial window 
(OPTION A), the motivation for which is discussed above. This procedure facilitated 
several additional surgical procedures also contained in this protocol that we have employed 
in previous studies (Fig. 1): First, we show how to combine window removal and 
replacement with durotomy and/or bone growth removal (OPTION B) in situations where 
thickened dura or skull regrowth have compromised image quality, thus enabling prolonged 
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optical access to the tissue beneath the window (local cleaning of skull regrowth and/or 
removal of the dura method was used in approximately 70% of mice included in two of our 
studies involving chronic imaging in awake mice13,15; see below; for a previous example of 
chronic imaging prior to and following bone regrowth removal, see also Fig. 2A in ref. 14). 
Second, window removal and replacement has allowed precisely targeted delivery of viral 
vectors and anatomical tracers to cortical areas that have previously been delineated using 
epifluorescence imaging in awake mice13-15 (for specific examples of awake functional 
maps and subsequent targeting of viral injection of calcium indicators, see Anticipated 
Results and Fig. 1A,C in ref. 13). This procedure also improves the reliability of injections, 
as substantially less brain edema occurs following window removal as compared to 
following initial craniotomy (our procedure for volume injections is described in 
Supplementary Method). Third, by replacing our cranial window with one that is glued to a 
precisely positioned microprism, we have achieved simultaneous, chronic, awake two-
photon imaging of precisely targeted cortical columns14 (OPTION C).
The replaceable cranial window approach we have employed is quite versatile, and should 
also enable several additional procedures not previously described (and thus not covered in 
this protocol). For example, temporary replacement with a cranial window with a 120 μm – 
1000 μm hole at a targeted location allows pipette access for stable two-photon imaging of a 
nearby, pressurized cortical area during cell-attached recordings (A. Kerlin and S. 
Chatterjee, unpublished data), and allows application and washout of various drugs during 
simultaneous imaging in awake mouse cortex (G. Goldey and M. Andermann, unpublished 
data).
Experimental Design
Several general and specific considerations discussed below and throughout the protocol can 
facilitate surgical training and adaptation of the procedures described below. It is helpful to 
begin training on a window implant surgery with as few additional challenging factors as 
possible. For example, it is useful to begin surgical training using healthy, young adult mice 
(P45-P90) wild-type (e.g. C57Bl/6) – in our experience, adolescent mice (e.g. P20-P35) 
have softer skulls and higher rates of skull growth, while older and/or overweight mice have 
thicker skulls and often respond more variably to anesthesia. It is also useful to begin by 
performing craniotomies on dorsal cortical regions that are distant from major sinuses and 
skull sutures (to avoid the risk of excessive bleeding). Once proficiency is achieved (which 
typically requires >2-4 weeks of daily practice), one can attempt more challenging 
adaptations (e.g. craniotomies in adolescent mice with more pliable skulls16, see Figs. 2a-b; 
or more lateral craniotomies (as employed in ref.15; see also Figs. 2c-i). This protocol 
focuses on window implants optimized for posterior visual cortex. When adapting these 
methods to other cortical regions of varying surface curvature, medial/lateral position, and 
proximity to sinuses, it will be useful to vary both the thickness and diameter of the cranial 
window (for further discussion, see CUSTOM MATERIAL SETUP). Once appropriate 
parameters are determined, window clarity can be maintained for several weeks to months 
following the initial implant, and following window removal/replacement (Figs. 2c-i and 
ANTICIPATED RESULTS).
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While it may be possible to image immediately following cranial window implant or 
window replacement (see Fig. 2 in ref. 14), we find it useful to wait at least 10 days after 
any surgical procedure prior to imaging, for several reasons. First, this allows the animal to 
recover from anesthesia and any long-lasting effects of drugs employed such as atropine and 
dexamethasone. Second, while we have not evaluated immune responses systematically 
across time, we do not find evidence of significant microglial or astroglial activation at 
several weeks to months following either a single window implant or following window 
replacement (Supplementary Fig. 1; N=4 mice; see also ref. 6 for additional discussion of 
potential immune responses following chronic window implant).
Activity of many individual neurons and long-range axonal boutons can be recorded 
simultaneously across all cortical depths via insertion of a 1 mm reflective glass 
microprism14. While qualitatively normal visually-evoked responses in mouse V1 can be 
observed as soon as the day following prism insertion, image clarity continues to improve 
across weeks14. In our experience, installation of the initial cranial window (PROCEDURE 
Steps 1-78) during a prior surgery preceding prism implantation is advantageous for several 
reasons: First, there is far less edema following window removal than during initial 
craniotomy, thus decreasing bleeding and increasing the precision of the insertion. Second, 
accurate functional targeting of prism location and angle of entry is possible. Third, 
separating the craniotomy/headpost and microprism implantation surgeries may decrease the 
risk to animal health inherent in longer, combined surgeries. As discussed in ref. 14 and in 
ANTICIPATED RESULTS, a useful control when establishing the microprism implant is to 
compare neural activity in superficial layers following microprism implant with activity 
patterns obtained through standard imaging methods from superficial cortex. Similarly, 
insertion of the prism to image the same columns from different directions (in different 
mice) can provide insight into the effects of connections that may be severed for any given 
tangential angle of prism insertion (e.g. prism imaging face pointing medial or lateral).
MATERIALS
REAGENTS
Wild-type (C57Bl/6) or transgenic mice (variable); (Charles River or Jackson Laboratories)
CAUTON. Any experiments using animals must be conducted in accordance with 
institutional and national guidelines and regulations.
Nair (CVS; item no. 339818)
Envirocide (Moore Medical; item no. 13-3324)
Benzalkonium chloride (Moore Medical; item no. 44018)
Betadine solution, 19% povidone-iodine topical solution (Moore Medical; item no. 77911)
Mineral oil (Fisher BioReagents; item no. BP26291)
70% Ethanol (Acros Organics; item no. 04-355-454)
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Methanol (Sigma-Aldrich; item no. 34860)
Black tempora powder paint (Blick; item no. SAR227185)
Kwik-Cast (WPI; item no. Kwik-Cast)
Kwik-Sil (WPI; item no. Kwik-Sil)
Loctite® liquid super glue, clear, 0.14 oz (WB Mason; item no. LOC1647358)
Grip cement kit, powder & solvent (Dentsply; item no. 675570)
C&B metabond quick (Parkell; item no. 242-3200)
Drugs—Sulfatrim (Patterson Veterinary; item no. 50383082316)
Sodium chloride injection [0.9%], fliptop plastic vial, 10 ml (Moore Medical; item no. 
55277)
Meloxicam (NSAID analgesic) injection, 5 mg/ml, 20 ml vial (Patterson Veterinary; item 
no. 07-890-733)
Isoflurane (Patterson Veterinary; item no. 07-878-1636)
CAUTION. Operations involving the use of isoflurane should be conducted in a well-
ventilated room to prevent the accumulation of anesthetic vapors.
Cefazolin, 1 gram vial (Patterson Veterinary; item no. 07-802-5851)
Puralube ophthalmic ointment (Patterson Veterinary; item no. 07-888-2572)
Dexamethasone injection [4mg/ml] (Patterson Veterinary; item no. 07-839-1921)
Atropine sulfate injection [1/120 grain] (Patterson Veterinary; item no. 07-869-6061)
Mannitol [20%] injection (Patterson Veterinary; item no. 07-869-7681)
Medical grade oxygen (LifeGas; item no. varies on canister size)
Gel foam (Moore Medical; item no. 2928)
Vetbond (Patterson Veterinary; item no. 07-805-5031)
Consumable supplies—Ultra-Fine™ II short needle insulin syringe (Moore Medical; 
item no. 77589)
1.0 ml syringes, luer-lok (Moore Medical; item no. 51415)
1.0 ml syringes, luer-slip (Moore Medical; item no. 96300)
BD 10ml sterile syringes (Moore Medical; item no. 8821)
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BD 25G 1” needle (Moore Medical; item no. 28099)
BD 27G 0.5” needle (Moore Medical; item no. 8838)
BD Brand isopropyl alcohol swabs (Fisher Scientific; item no. 13-680-63)
EF4 drill bits (Microcopy Dental; item no. EF4)
FG1/4 drill bits (Microcopy Dental; item no. FG1/4)
FG4 drill bits (Microcopy Dental; item no. FG4)
1.0mm MicroPrism, Al-coated hypotenuse (Tower Optical; item no. MPCH-1.0)
Teflon coated, platinum iridium EEG (Plastics One; item no. MS333/9A)
EEG mounting holder (Plastics One; item no. MH-325-E)
Surgical skin marker (Fine Science Tools; item no. 18000-30)
Double, one end tapered cotton tip medical applicator (Quick Medical; item no. 821-
WCDBL)
Non-woven surgical sponges (Patterson Veterinary; item no. 07-847-3539)
Kimwipes (Fisher Scientific; item no. 06-666)
3 1/2″ × 9″ sterilization pouch (Moore Medical; item no. 40390)
5 1/4″ × 10″ sterilization pouch (Moore Medical; item no. 40391)
1″ autoclave tape (Moore Medical; item no. 17411)
Sterile Towel Drapes 18″ × 26″ (Moore Medical; item no. 14170)
Corning 24 well cell culture cluster tray (Fisher Scientific; item no. 09-761-146)
Sofloop face masks (Moore Medical; item no. 53858)
Sterile surgical gloves (Moore Medical; item number is size-specific)
Surgical gown (Moore Medical; item number is size-specific)
Surgical tie-back cap (Moore Medical; item no. 53501)
Glass microscope slides (Fisher Scientific; item no. S95352)
Surgical tools—Bonn Strabismus scissors, ToughCut®, straight (Fine Science Tools; 
item no. 14084-09)
Vannas spring scissors, 3mm cutting edge, straight (Fine Science Tools; item no. 15000-00)
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Dumont #5 forceps, standard, Dumoxel (Fine Science Tools; item no. 11251-30)
Dumont #5SF forceps (Fine Science Tools; item no. 11252-00)
Dumont #5/45 forceps (Fine Science Tools; item no. 11251-35)
Iris forceps, straight (Fine Science Tools; item no. 11064-07)
Bonn micro probe, angled 45° (Fine Science Tools; item no. 10032-13)
Scalpel handle, item no. 3 (Fine Science Tools; item no. 10003-12)
Scalpel blades, item no. 10 (Fine Science Tools; item no. 10010-00)
Hot bead sterilizer, 8cm (Fine Science Tools; item no. 18000-45)
Replacement beads for hot bead sterilizer (Fine Science Tools; item no. 18000-46)
Stainless steel instrument tray and solid flat cover (Patterson Veterinary; item no. 
07-804-0008)
Calipers (McMaster-Carr; item no. 2325A75)
Castroviejo surgical calipers (Fine Science Tools; item no. 18000-35)
EQUIPMENT
CUSTOM MATERIALS
• Titanium headposts
○ Custom designed titanium headposts (see Supplementary Fig. 2; H.E. Parmer). 
While stainless steel or aluminum headposts may also be used, we chose to us titanium 
because it demonstrates increased biocompatibility and decreased corrosion during 
long-term implantation18-19, while remaining cost-effective (~$4 each when purchased 
in bulk) and precisely replicable across labs.
• Imaging wells
○ Buna-N O-Rings, size 015 (McMaster-Carr; item no. 9452K59)
○ Buna-N O-Rings, size 017 (McMaster-Carr; item no. 9452K71)
○ Cyanoacrylate (WB Mason; item no. LOC1647358)
• Cranial windows and microprism assemblies
○ 3 mm round coverglass (Harvard Biosciences; item no. W4 64-0720)
○ 5 mm round coverglass (Harvard Biosciences; item no. W4 64-0700)
○ 8 mm round coverglass (Harvard Biosciences; item no. W4 64-0701)
○ Norland optical adhesive, no. 71 (Norland Products, Inc.; item no. 7106)
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○ Ultraviolet lamp; 365 nm (Cole-Palmer; item no. UX-97603-05)
○ ELC-410 Light curing system (Thorlabs; item no. CS410)
○ Dumont ceramic tip forceps (Fine Science Tools; item no. 11210-60)
○ Incubator (Fisher Scientific; item no. 11-690-625D)
○ Aluminum coated microprism (Tower Optical; item no. MPCH-1.0)
SURGICAL EQUIPMENT
Small animal stereotaxic instrument with digital display console (KOPF; item no. 940)
Mouse gas anesthesia head (KOPF; item no. 1923-B; includes nose cone)
Non-rupture ear bar, mouse (KOPF; item no. 1922)
Universal stereotaxic holder (KOPF; item no. 1772-F2)
Heating pad bundled with probe and temperature controller (CWE inc.; item no. TC-1000)
Adjustable stage platform for 502600 series (WPI; item no. 502600)
Solid aluminum optical breadboard, metric (Thorlabs; item no. varies depending on size)
Clamping fork (Thorlabs; item no. CF125 or CF175)
General purpose clamp (Thorlabs; item no. CL5)
Pedestal post holder, spring-loaded hex-locking thumbscrew (PH30E/M)
12.7 mm stainless steel optical post (Thorlabs; item no. varies depending on size)
Right-angle post clamp (Metric), fixed 90° adapter (Thorlabs; item no. RA90/M)
Plate clamp (Standa; item no. 4PC69)
M6 cap screw and hardware kit (Thorlabs; HW-KIT2/M)
M6 setscrew and hardware kit (Thorlabs; HW-KIT4/M)
Dental drill—Econo dental delivery system (Aseptico; item no. ADU-07)
High speed dental handpiece (Aseptico; item no. AHP-96)
Hosing line to connect to 60-90 PSI compressed air supply
Vacuum line—1-way stopcock, luer lock (WPI; item no. 14038-10)
4-port manifold (WPI; item no. 14055-2)
Surgical suction hose, 6' (Patterson Veterinary; item no. 07-811-7922)
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Suction unit plastic canisters with lids, 1200cc (Patterson Veterinary; item no. 07-865-6131)
Tygon tubing (Cole-Parmer; item no. 06408-64)
Luer valve assortment (WPI; item no. 14011)
Barbed tubing assortment (WPI; 5000890)
Monoject cannula, 18G × 1” (Kendall; item no. 8881202348)
Stereoscope—Zeiss stereo discovery V8 zoom microscope (Zeiss; item no. NT58-814)
Binocular phototube ergo stereo 5-45 (Zeiss; item no. 435100-0000-000)
Eyepiece PL 10x/23 Br. Foc. (Zeiss; item no. 444036-9000)
Heavy duty boom stand (Diagnostic Instruments Inc.; item no. SMS20-6)
Objective achromat S 0.5x FWD 134 mm (Zeiss; item no. 435215-9901-000)
Stemi mount with drive for column 32 (Zeiss; item no. 455094-0000-000)
PC computer (Dell or other)
Canon EOS 60D Digital SLR Camera Body (Canon; item no. 4460B003)
Camera adapter 60N-C 2/3″ 0.63x (Zeiss; item no. 426113-0000-000)
Standard lighting for surgical rig—Cold-light source Zeiss CL 6000 LED (Zeiss; item 
no. 4357009101000000)
Gooseneck dual 4,5/800 ECO (Zeiss; item no. 4355409004000000)
Focusing attachment f/ active d = 8mm (Zeiss; item no. 4170890000000000)
EasyLED ring light (Zeiss; item no. 4170969200000000)
Anesthesia delivery system—V -1 tabletop system (VetEquip; item no. 901806)
Dual delivery system (VetEquip; item no. 921400)
Isoflurane vaporizer (VetEquip; item no. 911103)
Regulator, oxygen (VetEquip; item no. 901305)
Vapor guard filter (VetEquip; item no. 931401)
Wye connector (VetEquip; item no. YO-124DV)
Induction chamber, 7 liter (VetEquip; item no. 941444)
Charcoal-filtered anesthesia scavengers (VetEquip; item no. 931401)
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REAGENT SETUP
Atropine sulfate—Dilute 1ml of atropine sulfate (1/120 grain) in 9 ml of sterile saline 
(0.9% NaCl) for injection, USP; store the solution at room temperature (20° C) and protect 
the vial from light. Properly stored atropine sulfate solution is stable until the expiration date 
of the atropine sulfate stock solution.
Cefazolin—Dissolve 1 mg cefazolin powder in 9 ml sterile water for injection, USP. Once 
the cefazolin powder has been mixed with a diluent it should be stored in the refrigerator 
and used within 7 to 10 days.
Metacam—Dilute 1 mL of meloxicam (5 mg/ml) (a generic equivalent of metacam) in 
sterile saline in 9 mL of sterile saline (0.9% NaCl) for injection, USP; store the solution in 
the refrigerator and protect the container from light and use within 28 days.
C&B Metabond—Mix two leveled scoops of powder (opaque or clear) with four drops of 
quick base and 1 drop of catalyst in a cold ceramic mixing dish that has been stored in the 
freezer (this will extend the window for application of Metabond).
Black Dental Cement—Mix three parts white dental cement powder (Grip Cement) with 
one part black Tempora powder paint (for light shielding purposes; some users prefer a 10:1 
mixture).
EQUIPMENT SETUP
Titanium head plate—We designed a titanium head plate implant to provide for stable, 
long-term head fixation. The implant is rigid, lightweight, and machined from Grade 2 
(0.063) thickness CP titanium (Supplementary Figs. 2a,c). It is well suited for visual 
experiments, as the orientation of the bars provide a large unobstructed viewing angle. Prior 
to use in surgery, sterilize the headpost implant using a hot-bead sterilizer. For details on the 
custom headpost clamp we use for securing the headpost, see Supplementary Fig. 2. As 
described below, the skull must be clean and dry (Supplementary Fig. 3) for successful 
adhesion to head plate.
Imaging well—Imaging wells are needed to form a stable water meniscus under the 
microscope objective and to aid in the attachment of light-blocking material during imaging. 
To make the wells, tightly glue two different sized O-rings together using cyanoacrylate 
(Supplementary Fig. 2a). Once the adhesive has dried, store the imaging wells in 
benzalkonium chloride and rinse with 70% ethanol prior to use.
EEG recording wires—Stable EEG recordings are important to monitor the animal's 
global brain state. To prep the EEG wires for implant, strip approximately 1mm of the 
Teflon insulation from the ends of the EEG wires using a pair of iris forceps, then bend the 
exposed portion of each wire at a 90° angle. Rinse the entire device with 70% ethanol prior 
to use.
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Cranial windows—The cranial windows we use are designed to provide clear optical 
access to the brain as well as to control brain motion. A schematic of cranial window 
construction is shown in Supplementary Fig. 4. The top portion is a single round 
coverglass (no. 1 thickness) whose outer margins extend beyond the lower portion (the part 
that rests on the brain) by 1-2 mm and rest on the skull. For the main procedure described in 
this paper—the headpost and 5 mm cranial window implant centered over lateral V1 
(PROCEDURE Steps 1-78)—all cranial windows implanted on the day of the craniotomy 
are composed of 3 layers of round, no. 1 cover glass. Choices of cranial window dimensions 
are dependent on the particular surgery, and require consideration of the nature of the field-
of-view (e.g., is it near a sinus? does it need to contain multiple regions of interest?), the 
curvature of the skull and brain surface at the imaging location (less curved regions require 
thinner cranial windows), and the thickness of the skull (which increases with age). Trial 
and error are usually required to determine proper window thickness (e.g. layers of 
coverglass glued together, see below). Insufficient pressure (e.g., using implants that do not 
extend and put pressure on the dura) usually results in dural thickening, skull regrowth, and 
increased brain motion. By contrast, excessive pressure can impede cortical blood flow.
For assembly, glue and cure additional layers of glass (one at a time) using optical adhesive 
and long wavelength UV light (Supplementary Fig. 4c), then warm the fabricated window 
in an incubator at 50° C for 12 hours to help strengthen the adhesive bonding. Store the 
cranial window in 70% ethanol at the start of surgery and rinse with sterile saline prior to 
use. To avoid failure during or after the implant, the cranial window must be screened for 
imperfections (such as incorrect amounts of optical adhesive or misalignment) under a 
stereoscope before use. If the amount of optical glue is spread too thin, air spaces can form 
and cause optical aberrations or coverglass detachment during implantation. Conversely, too 
much optical adhesive will result in overflow past the edges of the cranial window, 
effectively creating a larger diameter cranial window than the size of the craniotomy. This 
can be particularly problematic during cranial window replacements, as the skull tends to 
regrow and create a tight fit against the edges of the inner coverglasses of the initial cranial 
window (<100 μm tolerance).
Fashioned cotton-tipped applicator—Cut the end off of a cotton tipped applicator and 
use sandpaper to thin down the sides of the wooden applicator, starting approximately 5 cm 
from the end that was just cut. This portion of the cotton tipped applicator should be thinned 
down so that the applicator will begin to bow when excess pressure is used to hold the 
cranial window in place at the time of implant, which will prevent the cranial window from 
breaking and compromising the surgery (Supplementary Figs. 5a-c).
Microprism assembly—For microprism imaging (PROCEDURE OPTION C), the 
microprism assembly consists of a microprism attached to the bottom of a cranial window 
(using optical adhesive; Supplementary Fig. 4d,e). Once the imaging location and 
orientation in the brain has been determined (for details, see ref. 14), plan the final point of 
insertion of the microprism by creating a template for precise positioning and attachment of 
the microprism to the bottom of the cranial window. The procedure for creating this 
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template and attaching the prism are described below and illustrated in Supplementary Fig. 
4f-m (see also associated figure legend).
First, attach a digital camera to the surgical scope, and position it directly above the 
implanted cranial window with the objective perpendicular to the cranial window. Using 
digital illustration software (e.g. Adobe Illustrator), draw a circular template that is the same 
size as the current cranial window implant (Supplementary Fig. 4f, left). Then load the 
image of the brain that was taken orthogonal to the window's surface, and rescale it to fit 
inside the circular template. Next, zoom in on the image to determine where the incision will 
be made, then draw a line that is the same size of the bottom edge of the prism 
(Supplementary Fig. 4f, left). When selecting the line, be careful to avoid bisecting large 
cortical vasculature.
Next, print the image and tape it to the bottom of a glass microscope slide (Supplementary 
Fig. 4g). Apply a small drop of Kwik-Cast to the top of the slide (Supplementary Fig. 4h), 
directly over the taped image, align a single coverglass concentric with the image, and allow 
the Kwik-Cast to cure (Supplementary Fig. 4i). Use a fine-tipped applicator (i.e. broken 
cotton-tipped applicator) to apply a small drop of optical adhesive over the arrow on the 
template (Supplementary Fig. 4k), then position the microprism in place with a pair of 
ceramic-tipped forceps so that the imaging face is pointing in the same direction of the 
arrow (Supplementary Fig. 4l). Finally, cure the prism to the coverglass using a high-
intensity light curing system (Thorlabs; Supplementary Fig. 4m). Carefully remove the 
coverglass assembly from the Kwik-Cast and clean (by rinsing with methanol) if necessary; 
then use optical glue and the light curing system to add this layer to a standard cranial 
window, as shown in Supplementary Fig. 4e (bottom panel).
Handle the microprism-window implant carefully to avoid scratches, store in 70% ethanol at 
the start of surgery, and rinse with sterile saline prior to use.
Custom stereotax setup—For a detailed description of how to prepare the custom 
modifications to our Kopf Stereotax in order to transfer between earbars and headpost 
clamps in the same surgical plane, please see Supplementary Fig. 2d-f and associated text. 
Other brands of stereotaxic equipment (e.g. Stoelting, Narishige) can be similarly adapted.
Equipment setup for intracerebral injections—Pull a custom micropipette from a 1.0 
mm outer diameter (OD) glass capillary tube so length of the needle's taper (i.e. neck-to-tip) 
is > 2 cm and the needle tip has a small OD (~1 μm). Break the needle tip using a fine pair 
of forceps and use a light microscope (equipped with a reticle) to confirm that the OD of the 
tip is between 12.5-25 μm. While evaluating the OD under the microscope, check to make 
sure that the break is clean. Once the custom-pulled micropipette needle has been deemed 
acceptable for use, load it with the substance that is to be injected into the cortex using the 
Hamilton syringe priming kit.
PROCEDURE
CRITICAL. Any experiments using animals must be conducted in accordance with 
institutional and national guidelines and regulations.
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HEADPOST & CRANIAL WINDOW IMPLANT (2-4 HOURS)—1| Pre-operative care 
To prevent neural edema during or after the craniotomy, administer the anti-inflammatory 
synthetic glucocorticoid dexamethasone sodium phosphate (4.8 mg/kg, 4 mg/ml 
concentration) intramuscularly (IM) into the quadriceps, 4-8 hours prior to surgery, with a 
short needle insulin syringe.
CAUTION. All experiments using animals should be in accordance with institutional and 
national guidelines.
2| Check isoflurane and oxygen levels to make sure there is enough for the entire duration of 
the surgery.
3| Turn on heating pad, LED and gooseneck lights for surgery.
4| Anesthesia Direct the airflow of the anesthesia system to the induction chamber and turn 
it on, allowing it to charge for one minute at 3% isoflurane in 100% oxygen (0.5-1 L/min). 
CRITICAL STEP As an alternative to steps 4-5, animals can be pre-anesthetized with an 
intraperitoneal injection of ketamine (100 mg/kg) and xylazine (15 mg/kg), which lasts 
longer than isoflurane (tens of minutes) and can facilitate placement of the mouse into the 
earbars (see below).
5| Place the mouse inside the induction chamber and allow the anesthetic to take effect. 
Thorough sedation typically occurs between 60-90 s, although this depends on the age and 
size of the mouse. Hallmark indicators include slower, steady breathing rates (~ 1 cycle per 
second) coupled with the absence of toe-pinch reflex; physical tests should be administered 
after the animal is positioned in the stereotax.
CAUTION. Operations involving the use of isoflurane should be conducted in a well-
ventilated area with active scavenging to prevent the accumulation of anesthetic vapors.
6| Transferring the mouse from the induction chamber to the stereotax Once the mouse is 
fully sedated, turn off the isoflurane and oxygen, then use the flush valve to flush the 
induction chamber with oxygen to prevent experimenter inhalation of isoflurane.
7| Redirect the airflow of the anesthesia system to the stereotax.
8| Carefully remove the mouse from the induction chamber, placing the mouse abdomen-
down on the heating pad, which should be pre-warmed and set to 37.5 ±1 °C.
9| Administer maintenance levels of anesthetic for the remainder of the surgery; 1.5% 
isoflurane (range: 0.9-1.8%) in 100% oxygen (0.5 l/min). Breathing should be regular and 
shallow. Sparse heaving/gasping (once every 3-4 s) is an indication that a lower isoflurane 
level is required or that the height of the base supporting the body needs to be adjusted to 
minimize strain on the diaphragm and neck. Conversely, irregular rapid breathing and/or a 
palpable response to the toe-pinch reflex indicates that the isoflurane level should be 
increased. Once the user has become proficient in monitoring levels of anesthesia and 
postural adjustment, rates of successful recovery from surgical anesthesia should exceed 
90%. If rates remain low, consider using non-invasive blood pressure monitoring (and/or 
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blood gas monitoring) to determine the anesthetic level (and body posture; see below) that 
ensures stable physiological parameters within the normal range throughout the surgery.
10| Loading the mouse into the stereotax With the abdomen still resting on the heating 
pad, use your dominant hand to gently hold the mouse's head, while using the index finger 
on your free hand to gently drop the lower jaw to expose the incisors.
11| Insert the top, central incisors into the hole located on the inside base of the mouse 
anesthesia adapter of the stereotax (the nosecone shield must be retracted behind this hole).
12| Once the incisors are in place, advance the nosecone over the snout (Fig. 3a), but not so 
far that motion of the mouse's head is restricted, as this may hinder placement of the ear bars 
in correct position.
TROUBLESHOOTING—13| Ensure that the temperature probe remains properly 
positioned to measure body temperature accurately.
14| Place the unfolded surgical gauze on the dorsal surface of the mouse's body for 
additional insulation (Fig. 3a).
15| Cover the eyes generously with Puralube ophthalmic ointment to prevent drying and 
cataract formation (Fig. 3a).
16| Administer atropine (0.216 mg/kg atropine sulfate and 3.6 mg/kg sterile saline; ~0.1 cc 
of 10X-diluted atropine) intraperitoneally (IP). Atropine is a competitive antagonist of 
muscarinic cholinergic receptors and helps prevent obstruction of the airways by acting on 
the parasympathetic nervous system to inhibit the salivary and mucus glands. Check the 
level of anesthesia and positioning of the mouse's body before continuing – the body should 
be positioned so that ear bars elevate the head by only a few millimeters with respect to the 
trunk. Excessive head elevation can impair breathing.
17| Engaging the ear bars to secure the head To secure the head of the mouse in the 
stereotax, position each non-puncture ear bar in the external auditory meatus within the ear 
canal (Fig. 3a).
CRITICAL STEP. It is important that ear bar placement is accurate and that the pressure 
applied is sufficient to prevent any movement, while preserving moderate intra-ocular 
pressure (to prevent cataract formation). Failure to ensure correct placement and pressure 
may result in respiratory problems, skull fracture and/or puncturing of the eardrum.
18| Advance the nose cone cover over the snout so that it is approximately 2-3 mm past the 
tip of the nostrils. This step will push the whiskers towards the eyes of the mouse. To avoid 
cutting the whiskers (which represents an additional source of stress upon recovery), use 
Paralube to temporarily affix them to the snout (Fig. 3a).
19| Hair removal Trim the hair on the scalp with a pair of fine scissors (Fig. 3b).
CAUTION Be careful not to pierce the skin.
Goldey et al. Page 15
Nat Protoc. Author manuscript; available in PMC 2015 May 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
20| Apply a depilatory agent (e.g. Nair) and massage into the scalp for a maximum of 30 s 
using a sterile cotton-tipped applicator (Fig. 3c).
21| Remove the depilatory agent using sterile cotton-tipped applicators. This should result in 
a hair-free area on the scalp that extends 1-3 mm beyond the perimeter of skin to be excised, 
ensuring asepsis by eliminating the presence of hair under any subsequent application of 
dental cement. Avoid application on the skin within 2 mm of the eyes. Alternatively, 
shaving may be acceptable if care is taken to avoid small cuts and to remove debris.
22| Scalp incision Remove any remaining hair using isopropyl alcohol swabs (Fig. 3d) and 
apply betadine solution using sterile cotton-tipped applicators (Fig. 3e). Repeat this washing 
procedure three times, alternating between alcohol and betadine, leaving the final 
application of betadine on the skin (Fig. 3e).
23| Hold a pair of #5/45 forceps in your non-dominant hand and use them to lightly grasp 
approximately 2-3 mm of skin between the eyes. Carefully pull this skin forward until the 
epidermis over the medial aspect of the skull is pulled taut to allow for an easier and more 
precise incision.
24| Hold the scalpel handle attached to a sterile #10 blade in your dominant hand and start 
the incision at the midline, approximately 3 mm posterior of the eyes. The length of the 
incision should be approximately 12-15 mm long (Fig. 3f,g).
CRITICAL STEP. When cutting in PROCEDURE Steps 24 and 25, it is crucial to 
maintain a 1-2 mm strip of bare epidermis along the perimeter of the hairline to maintain 
asepsis (Fig. 3h,i).
25| To excise the epidermis from the scalp, continue holding the #5/45 forceps in your non-
dominant hand and use them to pull the skin taut at the top left side of the incision; using a 
pair of push scissors to excise the skin over the left hemisphere of the skull (Fig. 3g-h). Use 
the same technique to remove the remaining skin on the right hemisphere (Fig. 3i).
CAUTION. Take extra precaution when cutting near the eyes and ears to prevent disruption 
of normal skin tension and/or severing any nerves or blood vessels that are part of these 
sensory organs (as either of these outcomes could delay healing or cause a disruption of 
vision/hearing).
26| Use a pair of #5/45 forceps to remove any remaining periosteum. If this connective 
tissue has already dried to the surface of the skull, use a #10 scalpel blade to scrape it off.
27| Finish cleaning any remnants from the skull using sterile cotton-tipped applicators 
moistened with sterile saline.
CRITICAL STEP. PROCEDURE Steps 26 and 27 will help ensure permanent adhesion of 
headpost to skull. This procedure requires that the mouse skull is secured properly in the ear 
bars to prevent skull movement during cleaning.
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28| Marking the center coordinates of the craniotomy Measure the desired coordinates with a 
pair of calipers and use a scalpel blade to lightly mark each axis. The points at which these 
lines intersect will designate the center of the craniotomy (Supplementary Fig. 3a). Please 
note, the steps we describe below involve a 5 mm cranial window implant in the left 
hemisphere, centered over mouse primary visual cortex (V1). The center coordinates we use 
for this particular cranial window implant are 3.10 mm lateral from lambda, and 1.64 mm 
anterior of the lambdoid suture.
29| With a pneumatic dental drill, use a FG¼ dental carbide to lightly etch this point for 
better visibility, which is necessary for accurate headpost placement (Supplementary Fig. 
3a).
30| Retraction of lateral muscles Use a pair of #5/45 forceps (with the tips closed together) 
to tease away the lateral muscles connected to the temporal suture (Supplementary Fig. 
3b). Gently insert the closed tips directly at the point where muscle attaches to the suture 
connecting the temporal and parietal plates, beginning approximately 2-3 mm behind the 
eye. Once an initial separation of bone and muscle has been achieved, gently run the closed 
tips of the forceps in the posterior direction—separating the muscle from the skull until the 
temporal and parietal plates meet the lambdoid suture. Then use Vetbond to fix the retracted 
muscle in place to maintain a low profile (Fig. 4a). This step should result in the exposure of 
approximately 2-3 mm of the temporal plate.
CRITICAL STEP. PROCEDURE Step 30 is essential for a well-centered headpost implant 
with respect to the desired coordinates of the craniotomy (in this case, lateral V1). Muscle 
retraction will also increase the surface area of exposed bone tissue that will be available as 
a contact point for C&B Metabond, thus ensuring structural integrity of the implant.
CRITICAL STEP. Be extremely cautious when working near muscles and connective 
tissue located near the lateral edge of the lambdoid suture (where it meets the temporal and 
parietal plates) to avoid damage to superficial auditory nerves. As muscle is retracted closer 
to the posterior regions, there is higher likelihood of bleeding due to underlying vasculature. 
If bleeding does occur, irrigate the affected area with sterile saline and apply gel foam if 
bleeding persists.
31| Tracing the craniotomy Using a pair of Castroviejo surgical calipers set to the radius of 
the craniotomy, place one of the two teeth in the center coordinate that was etched in 
PROCEDURE Step 29, and use the other tooth to trace the circumference of the craniotomy 
using a surgical skin marker (Fig. 4a).
32| Implanting EEG wires Secure the EEG mounting holder to a movable stage (see 
Equipment Setup and Supplementary Fig. 6a). CRITICAL STEP. Implanting wires for 
the EEG (PROCEDURE Steps 32-37) can be useful for long-term monitoring of brain 
states, but is not recommended during initial training on basic cranial window implant 
methods.
33| Use an FG¼ dental carbide to drill small holes in the locations where the EEG wires are 
to be implanted (note that the active and reference electrodes are positioned in one 
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hemisphere, while the ground is anterior to Bregma in the opposite hemisphere; 
Supplementary Fig. 6b).
34| Load the EEG into the mounting holder (Supplementary Fig. 6a) and position the wires 
in close proximity to the surface of the skull. Then carefully position each wire over its 
respective implant site (PROCEDURE Step 32); the tips of the wires should be bent at 90° 
(see Equipment Setup) and positioned to rest flat on the skull directly adjacent to their 
respective implant site (Supplementary Fig. 6c).
CRITICAL STEP. PROCEDURE Step 32 is designed to enable proper placement of the 
wires onto the surface of the dura (Supplementary Fig. 6). Move each of the wires into its 
implant site (Supplementary Fig. 6d) and secure it in place using a small amount of 
Vetbond or cyanoacrylate (Supplementary Fig. 6e). Ensure that the glue has fully hardened 
before implanting the next wire.
36| Repeat PROCEDURE Step 35 to finish implanting the other two wires of the EEG.
37| Once all of the wires have been implanted, carefully remove the EEG port from its 
holder and position of the wire leads well outside of the range of the craniotomy 
(Supplementary Fig. 6f). If necessary, use Vetbond to secure the wires in place and prevent 
movement during the headpost implant (PROCEDURE Steps 38 – 40).
CRITICAL STEP. Substantial clearance of the wires from the craniotomy is necessary to 
prevent damage, because subsequent steps involve drilling in this area.
38| Installing the titanium headpost Clean the skull of any dried blood or debris using 
sterile cotton-tipped applicators moistened with sterile saline.
39| Position the headpost over the center of the craniotomy so that it rests roughly in the 
same plane as that expected for the cranial window implant. The headpost should make solid 
contact with two locations on the skull. Once the headpost is correctly positioned, add two 
small drops of cyanoacrylate to secure an initial attachment to the skull. Apply light pressure 
until the cyanoacrylate has completely dried (Supplementary Fig. 6f; see also Fig. 4b).
CRITICAL STEP. For more lateral headpost implants, varying degrees of medial head tilt 
are required in order for the headpost to be co-planar with the cranial window implant 
(which simplifies chronic imaging). In addition, the ipsilateral ear bar may interfere with 
placement of the headpost. If this occurs, loosen the ipsilateral ear bar and retract it slightly 
from the external auditory meatus. Then carefully rotate the skull towards the contralateral 
side (so that the center coordinate of the craniotomy is facing upwards), and advance the ear 
bar back into place to support the skull.
CAUTION. Ensure that the repositioned ear bar is not applying pressure below the 
mandible to avoid obstruction of breathing.
TROUBLESHOOTING—40| After the headpost has been secured in place, apply a 
generous amount of C&B Metabond to the outside perimeter, covering any exposed bone to 
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ensure a complete seal with headpost, thus minimizing the chance of leakage when imaging 
using water-immersion objectives (Fig. 4c). Allow the C&B Metabond to fully harden 
before proceeding.
PAUSE POINT—In some cases, it may be useful to recover the animal, in which case 
headpost habituation and subsequent awake transcranial intrinsic imaging (following full 
recovery from surgery) can provide delineation of cortical brain regions (i.e. for subsequent 
targeted implants or injections). In this case, the exposed skull inside the headpost should be 
protected with Kwik-Cast and post-operative recovery steps should be followed 
(PROCEDURE Steps 76-78). Prior to subsequent surgery, PROCEDURE Steps 1-16 and 18 
should be repeated.
41| Placing the mouse into the headpost clamps Disengage the ear bars from contact with 
the mouse's head and slightly retract the nose cone shield in order to allow elevation or 
depression of the mouse's head so that it can be safely secured in the headpost clamps (see 
Equipment Setup). CRITICAL STEP. PROCEDURE Steps 41-48 improve stability during 
drilling, and ensure that the craniotomy region is coplanar with the microscope plane of 
focus, and that the window implant is roughly coplanar with the headpost (facilitating 
functional imaging).
42| Place the headpost clamps into the clamping forks on the breadboards that have been 
secured to the base of the stereotax (see Equipment Setup) and position them near the arms 
of the headpost. Then secure the clamping fork using a M6 cap screw.
43| Place one arm of the headpost into the secured headpost clamp, keeping the mouse's 
incisors in the holes of the nose cone (the secured headpost clamp may need to be 
repositioned to keep the incisors in place). Before tightening the screw on the Altos clamp, 
make sure that the arm of the headpost is resting flush with the bottom jaw of the clamp 
(Supplementary Fig. 2f).
CAUTION. If the headpost clamps are not properly aligned, excessive torque may be 
applied to the headpost and can result in dislocation from the skull.
44| Tighten the screw on the Altos clamp to secure headpost.
45| Position the second headpost clamp over the free arm of the headpost and secure the 
clamping fork. Finish securing the headpost by tightening the screw on the Altos clamp. 
Supplementary Fig. 2b illustrates the mouse supported in the headpost clamps after the 
cement has dried.
TROUBLESHOOTING—46| Once both arms of the headpost have been clamped, advance 
the nose-cone shield over the snout (relative to anatomical position) and slightly elevated. 
Note that the mouse's nose will now be slightly elevated and rotated about the body, which 
will likely prevent the nose-cone shield from fully advancing over the snout 
(Supplementary Fig. 2b).
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TROUBLESHOOTING—47| Adjust the height of the base supporting the body to correct 
for any height differences of the head that may have resulted from transferring the mouse 
from the ear bars to the headpost clamps.
48| Monitor the level of anesthesia to ensure it is sufficient before continuing with 
PROCEDURE Step 49.
49| Etching the craniotomy Use an FG¼ carbide attached to lightly etch the circumference 
of the craniotomy that was traced in PROCEDURE Step 31 (Fig. 4a).
CAUTION. When drilling the craniotomy, be careful to avoid drilling the same area for 
more than 2 s in order to prevent overheating due to friction (which may cause bleeding 
underneath the skull).
CAUTION. Be careful not to drill too deep in PROCEDURE Step 49; the goal is to create a 
physical boundary that can be used in the following steps that involve thinning the skull.
50| Take the cranial window (see EQUIPMENT SETUP) out of 70% ethanol and allow it to 
dry on the sterile surgical drape, then place the window above the skull and verify the 
precision of the circle etched in PROCEDURE Step 49. Make any necessary adjustments in 
the template so that the cranial window will fit snug inside the subsequent craniotomy.
51| After the template has been completed, use the top layer of the cranial window to 
determine if any C&B Metabond needs to be drilled away from the margins outside of the 
craniotomy to ensure direct, consistent contact with this part of the cranial window on top of 
the skull, then place the window back into 70% ethanol.
CAUTION. Handle with care to avoid scratching the cranial window.
52| Drill away excess C&B Metabond in these areas using a FG4 carbide; stop drilling once 
the skull is exposed (Fig. 5b).
CAUTION. If the headpost has been implanted at a very lateral location on the skull, it will 
be necessary to drill away a larger volume of C&B Metabond above the temporal aspect of 
the skull. This will likely also involve drilling through muscle tissue (Fig. 5b) that was 
previously secured with Vetbond (PROCEDURE Step 30).
TROUBLESHOOTING—53| Clear the skull of any debris by using the air gun on the 
dental delivery system. Wipe away any remaining debris away using sterile cotton-tipped 
applicators moistened with sterile saline.
54| Thinning the skull Thin down the skull around the outside perimeter of the craniotomy 
using an FG4 carbide (Fig. 5c). The main goal to be accomplished with thinning down the 
skull is to create a thin, yet homogenous, level plane for the uppermost layer of the cranial 
window to rest on.
CAUTION. When thinning the skull, irrigate with sterile saline intermittently to prevent 
overheating of the superficial brain mater. The thinned skull should not have any breaks in it 
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due to excessive drilling. Once this step is complete, the skull should then be slightly pliable 
when soaked in sterile saline, yet rigid when the bone tissue is dry.
CAUTION. Thinning the skull may result in bleeding underneath the skull due to 
overheating. To avoid this, do not allow the drill bit to remain in one spot for more than 2 s 
while thinning. It is important to note that there is vasculature embedded in the skull itself, 
as thinning the bone tissue will likely result in occasional spurts of skull bleeding. When this 
occurs, stop drilling and irrigate with sterile saline.
TROUBLESHOOTING—55| Once thinning has been completed, irrigate the skull with 
sterile saline, using sterile surgical sponges to soak up the fluid.
56| Complete drilling of the craniotomy using an EF4 carbide drill bit (Fig. 5c; Note: EF4 
provides more precision than FG¼). Stop drilling periodically to irrigate the skull with 
sterile saline. While drilling, small cracks between the bone flap and the surrounding skull 
will begin to separate and become slightly moistened by cerebrospinal fluid, giving the bone 
tissue a wet appearance. This is a hallmark indicator of having successfully drilled through 
the skull.
CAUTION. Be careful to not pierce through bone and dura when performing the 
craniotomy.
CAUTION. If any portion of the craniotomy rests over a sinus, drill over these areas with 
extreme caution.
TROUBLESHOOTING—57| Submerge the skull in sterile saline and gently probe the 
circular, non-drilled region of skull within the craniotomy (bone flap) to confirm that this 
region is completely separated from the surrounding skull. If any solid connections between 
the bone flap and the surrounding skull remain, use a Bonn micro probe to loosen or break 
any connections. If more drilling is required, soak up the sterile saline and complete drilling 
until the bone flap is loose around the entire craniotomy and re-submerge in saline.
58| Remove the bone flap with a pair of #5/45 forceps (Fig. 6a).
CAUTION. Craniotomies larger than 3 mm have increased risk of damaging the brain upon 
removal of the bone flap. In these instances, a cantilever-like downward motion of the bone 
flap at the opposite end the craniotomy can be prevented using a Bonn micro probe.
TROUBLESHOOTING—59| Irrigate the exposed brain with sterile saline. If bleeding 
occurs and is difficult to stop, apply gel foam and continue to irrigate. Once bleeding has 
ceased, keep the brain submerged in sterile saline (Fig. 6a, left).
60| Implanting the cranial window Load and secure the fashioned cotton-tipped applicator 
into the stereotax micromanipulator (Fig 6b, see also Equipment Setup; Supplementary 
Fig. 5).
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61| Remove the cranial window from the 70% ethanol bath and allow it to dry on the sterile 
drape.
62| Use a pair of #5/45 forceps to hold the cranial window and add a few drops of sterile 
saline to the top layer; this will disrupt the surface tension of the saline and allow the cranial 
window to sink below the surface. Once the cranial window is fully submerged, use #5/45 
forceps to position it over the craniotomy.
63| Position the micromanipulator so that the fashioned cotton-tipped applicator is above the 
cranial window as it rests on the dura (which remains submerged in sterile saline).
CAUTION. Depending on the working distance of the objective being used in the surgical 
scope, the tilt and/or height of stereoscope itself may need to be adjusted in order to position 
micromanipulator arm vertically over the center of the cranial window.
64| Tighten the screw lock of the micromanipulator to disable rotational movement in the 
horizontal plane.
65| Manually lower the fashioned cotton-tipped applicator using the dorsal/ventral arm until 
it is resting directly on top of the cranial window.
CAUTION. Little to no pressure should be applied at this point.
66| If necessary, use #5/45 forceps to make any fine adjustments in the position of the 
cranial window so that the bottom cover glass in the window assembly will fit correctly in 
the craniotomy.
TROUBLESHOOTING—67| Carefully lower the stereotaxic arm until the fashioned 
cotton-tipped applicator begins to bow slightly. If the skull has been properly thinned 
(PROCEDURE Steps 54-69), the saline-soaked bone tissue will become slightly pliable and 
bend downward as the cotton-tipped applicator continues to increase the amount of pressure 
being applied to the surface of the cranial window (Fig. 6b).
CAUTION. Stop applying pressure when the cotton-tipped applicator begins to bow 
(Supplementary Fig. 5b), or if cortical blood flow is obstructed.
TROUBLESHOOTING—68| Soak up the sterile saline using sterile surgical sponges.
69| Use sterile Kim-wipes to remove any fluid beneath the top layer of the cranial window 
(the portion resting on the surface of the skull, see Fig. 6c).
CAUTION. Ensure that no fluid is removed from beneath the portion of the cranial window 
that is resting on the surface of the brain.
TROUBLESHOOTING—70| Once the inside of the well is dry, apply a small amount of 
Vetbond to create an initial seal between the top layer of the cranial window and the skull 
(Fig. 7a).
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CAUTION. Vetbond has a very low viscosity and tends to clog the applicators used to 
apply it. Check to make sure that the spout of the applicator is not clogged to avoid 
accidental overflow above the top layer of the cranial window. Do not allow Vetbond to 
spread over the top surface of the cranial window. As a further precaution, small drops of 
Vetbond can be applied to a sterile surface and dabbed onto the sides of the cranial window 
using an applicator.
TROUBLESHOOTING—71| Absorb any excess Vetbond using a sterile Kim wipe.
72| Apply C&B Metabond over any exposed skull and the portion of the cranial window that 
is resting on the skull (being careful to prevent any obstruction of visibility of the brain 
surface). Allow the C&B Metabond to fully cure before continuing to PROCEDURE Step 
73 (Fig. 7b).
73| Raise the vertical arm to lift the fashioned cotton-tipped applicator away from the 
surface of the cranial window.
74| Use cyanoacrylate to glue the imaging well (see Equipment Setup) to the surface of the 
titanium headpost.
75| Apply black dental cement to the inside and outside of the imaging well and to all 
regions of C&B Metabond for light-blocking purposes (see Drug and Reagent Setup; Fig 
7c). Ensure that additional dental cement does not rise appreciably above the cranial window 
margins to avoid damage to short working distance (e.g. 2 mm) imaging objectives.
76| Post-operative care At the end of the surgery, but before discontinuing anesthetic, 
administer analgesia (inject 0.50 mg/kg meloxicam, a non-steroidal anti-inflammatory 
(NSAID), subcutaneously, SC; alternative NSAIDs to meloxicam may be used, such as 
carprofen). Wait 10 minutes.
77| Discontinue anesthesia and allow the animal to wake. The mouse should be kept on the 
heating pad until ambulant.
78| Administer prophylactic antibiotics (cefazolin, 500 mg/kg injection, IM; and sulfatrim, 
1:32 in H2O) and allow the animal to recover.
CAUTION. All animal experiments must be performed in accordance with the guidelines 
and regulations held by the institution at which they are conducted in.
Applications involving removal and replacement of the cranial window: As described in 
the flowchart in Fig. 1, at a later date following the initial window implant,performing the 
following optional component procedures can enable various extensions of the initial cranial 
implant. Procedures for cranial window removal (OPTION A, required for subsequent 
options) and additional procedures prior to subsequent replacement of the chronic cranial 
window allow for (i) cleaning of the imaging area, including durotomy / bone growth 
removal (OPTION B), (ii) functionally-targeted intracerebral injection (Supplementary 
Text), and (iii) microprism implant for deep imaging across cortical layers (OPTION C). An 
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example of bone regrowth that will impair two-photon imaging in vivo is described in Fig. 
8a-c. Conducting OPTIONS A and B together allows extraction of this bone regrowth. The 
window removal/replacement strategies also allow for replacement with cranial windows 
containing drilled or laser-cut holes of various shapes and sizes allows stable cell-attached 
recordings (A. Kerlin and S. Chatterjee, unpublished observations) or pharmacological 
studies (G. Goldey and M. Andermann, unpublished observations) during anesthetized or 
awake imaging of pressurized, adjacent cortical regions.
OPTION A) CRANIAL WINDOW REMOVAL (15-30 MINUTES)—i| Repeat 
PROCEDURE Steps 1-16 and 18.
ii| Repeat PROCEDURE Steps 42-47.
iii| Fill the headpost well with 70% ethanol and wait at least 90 s.
CRITICAL STEP The goal of this and the next step is to disinfect and clean the headpost 
well of any debris.
iv| Remove the ethanol using sterile surgical sponges and/or sterile cotton-tipped 
applicators.
v| Use an FG4 carbide to shave down any cement above of the top layer of the cranial 
window (Fig. 8d). If the drill bit is kept completely orthogonal to the transverse plane, the 
cement can be drilled away without cracking the window.
vi| Use an FG4 drill bit to drill away the dental cement directly surrounding the cranial 
window, then clear the headpost well of any debris caused by drilling (i.e. by irrigation with 
sterile saline). This should result in exposure of the underlying skull (Fig. 8e).
vii| With a pair of #5/45 forceps in one hand, close the tips together and gently place them 
on top of the cranial window, and use a FG4 drill bit to drill away the portion of the cranial 
window that is resting on the surface of the skull (Fig. 8e). Continue to hold the forceps in 
place to prevent the center portion of the window from being ejected out of the craniotomy. 
If done cautiously, the center portion of the window should remain snug in the craniotomy, 
with no brain insult or bleeding (Fig. 8e).
TROUBLESHOOTING—CAUTION. If the cranial window's center portion (or ‘plug’) is 
not kept within the craniotomy upon completion of this step, two problems will likely occur: 
First, debris resulting from drilling will stick to the dura, which may irritate the brain and/or 
lead to infection and/or decreased optical clarity. Second, thinning down the skull 
surrounding the perimeter of the craniotomy (OPTION A, Step viii) will result in an inward 
expansion of bone-tissue, and in turn, a slightly smaller craniotomy (since the plug was not 
in place to resist this inwards expansion of bone). If the latter occurs, the new cranial 
window will not fit into the craniotomy and the surgery will have to be terminated. It is 
plausible that success may otherwise be achieved by not thinning down the skull, and 
instead replacing the current cranial window with a new window containing an extra inner 
coverglass for added thickness. This has been less fruitful of an approach since drilling away 
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the top layer of the cranial window often results in slight drilling into the skull, and thus 
inward expansion of bone tissue.
viii| Uniformly thin down the underlying skull as described in PROCEDURE Steps 54-55 
(Fig. 8e) so that adequate pressure can be applied when the new cranial window is 
implanted. This step is necessary in order ensure that the skull surrounding the craniotomy is 
as thin as it was following the original craniotomy (PROCEDURE Steps 54-57), despite 
subsequent increases in thickness due to Vetbond and C&B Metabond application 
(PROCEDURE Step 70) and skull regrowth and thickening during aging.
ix| Irrigate the inside of the headpost well using sterile saline to remove any debris.
x| Fill the inside of the headpost well with sterile saline and carefully remove the remainder 
of the cranial window from the inside of the craniotomy using a pair of #5/45 forceps.
OPTION B) DUROTOMY AND/OR BONE GROWTH REMOVAL (30-60 MINUTES)
—i| Remove the cranial window as described in Option A.
CAUTION. Before proceeding to OPTION B, Step ii, any bleeding that resulted from the 
cranial window removal should be under control.
ii| Use a Bonn micro probe to pierce the dura in an area that is devoid of cortical vasculature, 
or in an area where bone regrowth is present (Fig. 8f).
CAUTION. Two important variables should be considered before dura or bone tissue is 
removed from the craniotomy. First, as the length of time that the cranial window has been 
implanted prior to the durotomy increases, the thickness of the dura will typically increase 
(as well as the density and/or thickness of dural vasculature). Although this makes the dura 
much easier to differentiate from cortex, far more bleeding will occur during the durotomy. 
In this case, the surgeon should remain calm while performing the durotomy. The quality of 
the original cranial window implant (e.g., the degree of consistent pressure on the brain 
throughout the window) will determine the rate of dural thickening and whether osseous 
tissue beneath the cranial window also begins to emerge, rendering the cleaning procedure 
more challenging. For best results, it is recommended that high quality optics are used to 
analyze the state of the brain beneath the cranial window prior to this procedure. A skilled 
observer can easily differentiate the different categories of regrowth discussed above, and 
thus better plan for the steps required in the surgery.
iii| Use a pair of #5/45 (or #5SF) forceps to grab a hold of the dura where it was just 
previously punctured.
iv| With the dura in the grip of the forceps, gently peel it from the brain and tear it radially 
from the edge of the craniotomy. Then continue to tear the dura in a circumferential fashion 
until it has been completely removed from the cortex. Immediately irrigate with sterile 
saline and apply gel foam.
Goldey et al. Page 25
Nat Protoc. Author manuscript; available in PMC 2015 May 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
CAUTION. If the durotomy is being performed near a sinus, a pair of fine push-scissors 
should be used to cut the dura in order to prevent excessive bleeding from the sinus (Fig. 
8g).
TROUBLESHOOTING—v| Complete PROCEDURE Steps 60-75 to implant the cranial 
window (Fig. 8h). Make sure to have properly evaluated the cranial window prior to implant 
(see Equipment Setup for details).
TROUBLESHOOTING—vi| Complete PROCEDURE Steps 76-78 for post-operative care.
OPTION C) MICROPRISM IMPLANT FOR FUNCTIONAL IMAGING ACROSS 
ALL CORTICAL LAYERS (60-90 MINUTES)—CRITICAL. Below we describe, in 
greater detail, the protocol used for chronic calcium imaging in Andermann et al., 2013.
i| Remove the cranial window as described in OPTION A.
ii| Perform a large durotomy as described in OPTION B, Steps ii-iv.
iii| Load the straight-edge dissecting knife into the vertical stereotaxic arm and position the 
tip of the blade over the posterior aspect of cortex that is going to be incised. The blade of 
the knife should be facing the anterior aspect of the cortex, since the incision will be made in 
a posterior-to-anterior fashion. For incisions not made along this axis, try to choose an axis 
on incision that can be made parallel to the horizontal arm of the micromanipulator.
CRITICAL STEP. OPTION C, Step iii requires prior planning for successful results. Prior 
to implanting optical devices such as a microprism assembly, high-resolution pictures of the 
brain surface (after cranial window implant) must be taken and scaled for use as a template. 
This template will then be used to (1) construct the microprism assembly (a microprism 
glued below a standard cranial window) given the geometric specifications of the current 
cranial window implant (to allow precise anatomical implantation of the microprism) and 
(2) perform the cortical incision at a location that will allow proper placement of the implant 
(see Equipment Setup; Supplementary Fig. 4).
TROUBLESHOOTING—iv| Digitally zero the micromanipulator location once the blade 
touches the cortex, then slowly lower the blade to make an incision that is 10% deeper than 
the vertical height of the microprism. Irrigate with sterile saline periodically when 
performing the vertical component of the incision. Using a micromanipulator minimizes 
damage to cortex adjacent to the microprism insertion, and to underlying white mater. It also 
allows a slower, more precise incision.
v| Continue making the incision by driving the blade in a posterior-to-anterior fashion along 
the target incision—again, exceeding the total length of the incision by 10% of the length of 
the microprism. Irrigate with sterile saline periodically while performing the incision. 
Minimal, controlled back-and-forth motion (<100 μm) of the blade may further prevent 
brain compression or an excessively long incision.
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vi| Carefully retract the dissecting knife from the brain, then immediately irrigate the cortex 
with sterile saline and apply gel foam.
vii| Remove the dissecting knife from the micromanipulator and replace it with the vacuum 
line.
viii| To hold the microprism assembly from above (OPTION C, Step ix), first place an 18G 
Monoject blunt cannula (Kendall) on the tip of the vacuum line, then turn on the vacuum 
(standard wall vacuum pressure is sufficient).
ix| Remove the microprism assembly from the 70% ethanol and allow it to dry, then grip the 
assembly from above using suction (i.e. using the blunted cannula attached to a vacuum 
line).
x| Position the microprism assembly above the gel foam that is covering the incision.
xi| Remove the gelfoam from above the incision; if bleeding occurs irrigate with sterile 
saline reapply gel foam until bleeding subsides. Then adjust the rotational alignment of the 
microprism assembly so that the bottom edge of the microprism is in-line with the incision.
xii| Lower the microprism assembly and digitally zero its position when the lower edge first 
contacts the brain.
TROUBLESHOOTING—xiii| Insert the microprism assembly into the brain, lowering the 
vertical arm of the stereotax slowly until the top layer of the cranial window is resting on the 
surface of the skull. The implant should be lowered slightly (~100-200 μm) beyond the 
length of the microprism to ensure adequate pressure of the cranial window on the brain 
surface (as previously described).
xiv| If possible, advance the microprism assembly slightly (~200-400 μm) so that the 
imaging face can apply more pressure to the brain mater directly in front of it.
CRITICAL STEP. Failure to achieve an adequate amount of pressure between the imaging 
face and the brain mater in front of it may result in the accumulation of blood and/or dural 
growth, either of which will obstruct imaging through the microprism.
xv| Soak up the sterile saline using sterile surgical sponges.
xvi| Use sterile Kim-wipes to remove any fluid beneath the annulus of the top layer of the 
microprism assembly (the portion resting on the surface of the skull).
CAUTION. Ensure that no fluid is removed from beneath the portion of the microprism 
assembly that is resting on the surface of the brain.
xvii| Once the inside of the well is dry, apply a small amount of Vetbond to create an initial 
seal between the microprism assembly and the skull.
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CAUTION. Vetbond has a very low viscosity and tends to clog the applicators used to 
apply it. Check to make sure that the applicator is not clogged to avoid excess application. 
Do not allow Vetbond to be applied to the top surface of the cranial window.
xviii| Absorb any excess Vetbond using a sterile cotton-tipped applicator
xix| Apply C&B Metabond over any exposed skull and the portion of the microprism 
assembly that is resting on the skull (being careful to prevent any obstruction of visibility of 
the brain surface. Allow the C&B Metabond to fully cure before continuing to OPTION C, 
Step xx.
xx| Turn the vacuum line off, then raise the vertical arm to lift the cannula away from the 
surface of the microprism assembly.
xxi| Apply black dental cement to the inside and outside of the imaging well; make sure to 
cover all regions of C&B Metabond for light-blocking purposes (see Equipment Setup). 
Ensure that additional dental cement does not rise appreciably above the cranial window 
margins to avoid damage to short working distance (~2 mm) imaging objectives.
xxii| Repeat PROCEDURE Steps 76 – 78 for post-operative care.
TIMING. For approximate durations of each procedure, see Fig. 1. Note that while 
accuracy and adherence to protocol and sterility should always be favored relative to speed 
(particularly when long-term brain health is paramount), surgery times will often decrease 
substantially with practice.
TROUBLESHOOTING—See Table 1 for troubleshooting guidance.
ANTICIPATED RESULTS
The ability to separate these procedures into multiple, distinct surgeries over time helps 
ensure optimal cranial window optical clarity, high success rates, and increased accuracy of 
functionally targeted injections. With sufficient practice, a careful surgeon can achieve 
success rates upwards of 80-90%. Similarly high success rates can be achieved for window 
removal/replacement and associated procedures, including functionally targeted focal 
cortical injections and/or insertion of a chronic microprism. Following these procedures, we 
consistently found neural response properties in mouse primary visual cortex to be in the 
normal range (see refs. 12-15 for details). Below we describe some typical applications that 
outline the current and future value of these methods, and factors to consider when 
interpreting results.
Figure 9 illustrates the window implant and removal procedures described above, in an 
application to targeted two-photon calcium imaging of long-range axonal boutons. 
Following initial window implant, we use widefield intrinsic autofluorescence imaging in 
awake mice to identify visual cortical areas, as illustrated in Fig. 9a-b (65 days after initial 
implant; adapted from ref. 15). We then remove the cranial window for targeted AAV-
GCaMP3 calcium expression to within a cortical area (67 days after initial implant). We 
verified that GCaMP3 expression was restricted within a single visual cortical area (12 days 
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after AAV-GCaMP3 injection) by confirming that widefield GCaMP3 imaging of visually-
evoked responses did not demonstrate mirror reversals of the retinotopic map (Fig. 9c-d). 
Subsequently, two-photon calcium imaging was performed from long-range axonal boutons 
of the infected neurons, imaged in a downstream cortical area (Fig. 9e-g; 28 days after 
AAV-GCaMP3 injection). The clarity of the window is important for maintaining the ability 
to visualize individual axonal boutons in vivo (see also ref. 20). A similar workflow was 
used for imaging of cell bodies in other experiments (e.g. refs. 13, 15), including cell bodies 
as deep as cortical layer 515
The above example highlights the utility of sustained window clarity both prior to and 
following removal/replacement of the cranial window. Fig. 2d-i provides a second example 
of sustained window clarity at 4 months after initial window implant, as well as 2 months 
after window subsequent window removal/replacement. Two additional examples of five-
month timelines of window clarity and GCaMP3 expression, from initial implant through 
window removal/replacement and AAV-GCaMP3 injection, are shown in Fig. 10.
The protocols described above also facilitate targeted insertion of a microprism into cortex 
for long-term functional imaging. We could routinely record the same large set of cell 
bodies across all cortical layers across days and weeks in awake mice using calcium imaging 
through a microprism14 (Fig. 11a). This method allows both epifluorescence and two-
photon calcium imaging across all 6 cortical layers using a standard two-photon microscope 
(Fig. 11b). When imaging in primary visual cortex, neurons in all layers were driven by 
visual stimuli, allowing generation of visual response tuning maps throughout a cortical 
column (Fig. 11c; 21 days after microprism insertion). Visual response tuning of the same 
neurons imaged through the prism was stable across days (Fig. 11d; 21 and 23 days after 
prism implant).
Because in vivo functional imaging of individual axons and synaptic boutons has been 
restricted to superficial depths in cortex15,20 (~0-150 μm deep), we previously asked 
whether use of a microprism could enable monitoring of long-range axonal activity deep 
within the cortex (Fig. 11e). As in Fig. 9, we made a small injection of AAV-GCaMP3 into 
area V1, and inserted the prism into the posteromedial secondary visual cortical area (PM), 
an area densely innervated by V1 axons, with the prism oriented to face area V1. We 
observed robust single-trial visual responses of individual boutons at depths of 480-510 mm 
below the cortical surface (putative layer 5) during presentation of stimuli at multiple 
temporal frequencies and spatial frequencies at 1 day post-implant (Fig. 11f). Thus, this 
method extends in vivo functional imaging of axonal arbors15,20 to arbors that innervate 
deeper cortical layers. Further, the study of long-range projection axons via a microprism 
represents a less invasive application of this method with fewer caveats than for imaging of 
cell bodies near the prism face: while damage to long-range axonal boutons near the prism 
face cannot be ruled out (see below), these boutons report the activity of neurons whose 
dendrites are safely located millimeters from the prism implant.
In future, chronic two-photon imaging through a microprism may also be combined with 
voltage-sensitive indicators to monitor the flow of information through a cortical column in 
real-time. As discussed in detail elsewhere14, the chronic insertion of a 1 mm microprism 
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into cortex clearly is accompanied by damage to local neural processes and to the 
neurovascular unit. Care must be taken in interpreting neural data and validating results 
against known benchmarks14. Vascular remodeling immediately adjacent to the prism face 
can also occur over the course of weeks (see Supplementary Fig. 2 in ref. 14), and should be 
considered if studying neurovascular processes. Our protocol is designed to minimize 
cortical damage, in part by performing the procedure after window removal (i.e. with 
significantly less baseline cortical edema than when performed together with a craniotomy), 
by carefully limiting the extent of incision prior to prism insertion, and by positioning the 
prism and incision to avoid major blood vessels. Nevertheless, lasting changes in glial cells 
were limited to <100 μm from the prism face (see Fig. 1 in ref. 14), and visual response 
properties of the same neurons imaged prior to and several days following prism insertion 
remained largely unchanged (see Fig. 2 in ref. 14).
It is important to note that, following both standard craniotomies and prism insertions, some 
surgeries can result in window implants with residual patches of blood above the brain (e.g. 
Fig. 7c; blood patches may also accrue at the prism imaging face). In these cases (but not in 
the case of intracortical bruising due to excessive drilling), clarity will typically improve 
substantially as blood is absorbed over the span of days to weeks (see e.g. Supplementary 
Fig. 2 in ref. 14), enabling high-resolution two-photon imaging. Despite the fact that our 
cranial window is composed of multiple coverslips, subcellular spatial resolution is routinely 
achieved, as demonstrated by our ability to image neural activity of individual putative long-
range axonal boutons in superficial cortical layers15 (Fig. 9) and in deeper layers via a 
microprism14 (Fig. 11).
Concluding remarks
We have outlined a detailed set of versatile protocols that employ removable chronic cranial 
window implants for imaging in posterior cortex of awake, behaving mice. In the future, 
these methods can likely be modified for imaging in more lateral (cf. Figs. 2d-i) or anterior 
cortical regions. In addition, temporary replacement with a cranial window with a 120 μm – 
1000 μm hole at a targeted location should enable pipette access for stable two-photon 
imaging of a nearby, pressurized cortical area during cell-attached recordings (A. Kerlin and 
S. Chatterjee, unpublished data), and application and washout of various drugs during 
simultaneous imaging in awake mouse cortex (G. Goldey and M. Andermann, unpublished 
data). We look forward to working with other groups to further develop and standardize 
surgical procedures for use in mice as well as other model systems, such as rats, carnivores 
and non-human primates. Such collaboration is a key step towards effectively assessing 
results across a growing number of laboratories using chronic imaging to understand cortical 
structure, function, and plasticity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Online summary
This protocol describes how to implant a removable cranial window enabling 
manipulations such as targeted virus injections and microprism insertion, for one- and 
two-photon calcium imaging of the same cortical brain regions for several months.
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Figure 1. Experimental paradigm and surgical procedures involved in chronic imaging in awake 
mice
Flowchart showing the sequence of events that may be encountered during chronic imaging 
in awake, behaving mice. Surgical procedures (solid blue boxes) are described in detail in 
this protocol (see PROCEDURE). Numbers and approximate timings refer to corresponding 
steps in PROCEDURE section. Asterisks indicate that neither prior handling of mice nor 
EEG implantation are essential. Note that cranial window removal and replacement 
following initial imaging allows for several additional procedures that can extend the 
lifetime of the cranial window and allow flexible timing, increased brain stability, and 
reduced surgery times as compared to performing these procedures immediately following 
the initial craniotomy.
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Figure 2. Illustration of chronic window implants for awake imaging in adolescent and adult 
mice
(a-b) Images of a 3 mm cranial window implant over primary visual cortex (V1) of an 
adolescent mouse, taken on the day of surgery (a; postnatal day P22; anesthetized) and 4 
days later (b; awake and head-restrained). (c-i) Images of a 3 mm cranial window implant at 
a very posterior and lateral location in an adult mouse. (c) Skull outline of proposed 
craniotomy, extending laterally to the squamosal bone. (d) Image of the exposed brain 
submerged in sterile saline immediately following the craniotomy. (e) Implant appears clear 
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and brain appears healthy immediately following initial cranial window implant (day 0). 
Black arrow denotes the intersection of the transverse sinus and the caudal rhinal vein. (f) 
Image of the same implant as in e, but 117 days later, illustrating sustained window clarity. 
(g-h) Images prior to (g) and following (h) a demonstration of cranial window removal in 
the same mouse, 124 days after initial window implant. (i) Image demonstrating window 
clarity, 51 days after window replacement (see also Fig. 10). Experiments were approved by 
the IACUC at Harvard Medical School (HMS; panels a-b) and Beth Israel Deaconess 
Medical Center (BIDMC; panels c-i).
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Figure 3. Placement in the stereotax and initial skin incision
(a) Image of an anesthetized mouse after proper placement in the stereotax (PROCEDURE 
Steps 1-18). Blue arrows indicate the inflow and outflow of gas anesthesia (isoflurane and 
oxygen), with the nosecone advanced over the snout (PROCEDURE Step 12). The animal's 
body is resting on a feedback-regulated heating pad and has been covered with an unfolded 
surgical sponge (PROCEDURE Step 14; for thermal insulation). Ophthalmic ointment has 
been applied to the eyes (to prevent cataracts) and the earbars have been engaged into the 
external auditory meatus to secure the skull (PROCEDURE Steps 15 and 17). (b-e) Hair 
removal and preparation of the surgical site (PROCEDURE Steps 19-22). Hair is trimmed 
(b; PROCEDURE Step 19), and removed by depilation (c; PROCEDURE Steps 20, 21), 
followed by 3 alternating washes with 70% isopropyl alcohol (d) and betadine (e) to prepare 
the site for incision (PROCEDURE Step 22). (f-i) Making an incision in the skin. (f) A pair 
of #5/45 forceps pulls the skin taught while an incision (~12-15 mm) is made 
(PROCEDURE Steps 22-24). (g-h) Excision of the epidermis from the skull using forceps 
and push-scissors (PROCEDURE Step 25). (i) Image of the skull after full excision and 
prior to the removal of the periosteum (PROCEDURE Step 26). These surgical procedures 
(Figs. 3-8) were approved by the IACUC at BIDMC.
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Figure 4. Implanting the headpost
(a) The retracted muscle is fixed in place ~2-3 mm below the temporal bone suture using 
Vetbond (blue arrow; PROCEDURE Step 30). The perimeter of the 5 mm diameter 
craniotomy is traced using a sterile surgical skin marker (left; PROCEDURE Step 31). (b) 
The titanium headpost is centered on the skull and secured in place using a small amount of 
cyanoacrylate (PROCEDURE Step 39). Dotted white line (left) indicates plane of cross-
sectional viewing the associated schematic (right). Black arrows indicate headpost. (c) C&B 
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Metabond (white arrows) is applied to all areas surrounding the headpost for permanent 
attachment to the skull (PROCEDURE Step 40).
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Figure 5. Placing the mouse into the headpost clamps and drilling the craniotomy
(a) The mouse is removed from the ear bars and loaded into the headpost clamps for 
craniotomy (PROCEDURE Steps 41-48; this improves stability for drilling and, in some 
cases, facilitates imaging by positioning the cranial window in precisely the same plane as 
that spanned by the headpost). Dotted white line (left) indicates plane of cross-sectional 
view in the associated schematic (right). (b) The craniotomy is etched using an FG¼ carbide 
drill bit (left, unmarked; right, blue) and excess C&B Metabond is drilled away using an 
FG4 carbide (left, unmarked; right, grey) to expose the skull surrounding the craniotomy 
(PROCEDURE Steps 49-52). Previously exposed muscle tissue that was previously secured 
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using Vetbond (PROCEDURE Step 30) may become exposed (red arrows). (c) The skull is 
cleared of debris and the craniotomy perimeter is thinned using an FG4 carbide, which 
involves intermittent irrigation with saline to avoid overheating of the underlying brain 
(PROCEDURE Steps 53-55). Craniotomy drilling is then completed using an EF4 carbide 
(PROCEDURE Step 56).
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Figure 6. Cranial window placement
(a) The skull is submerged in saline (indicated by blue water drop symbol at top right) and 
the bone flap is removed using forceps (PROCEDURE Steps 57-59). (b) The exposed brain 
remains submerged in sterile saline and the cranial window is implanted into the craniotomy 
and held in place using a fashioned cotton-tipped applicator loaded into a stereotaxic 
micromanipulator (PROCEDURE Steps 60-67). (c) Saline is soaked up using surgical 
sponges and Kim-wipes (black arrow), except for directly under the cranial window 
(PROCEDURE Steps 68-69).
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Figure 7. Cranial window implant and placement of imaging well
(a) Vetbond is carefully and conservatively applied to create a thin seal between the skull 
and the sides of the top layer of the cranial window (blue arrows). Excess Vetbond is wicked 
away using a sterile Kim-wipe (PROCEDURE Steps 70-71). (b) C&B Metabond is applied 
to all areas inside of the headpost, including any exposed skull as well as the portion of the 
cranial window resting on the skull (white arrows; PROCEDURE Step 72). (c) The C&B 
Metabond has fully hardened and the fashioned cotton-tipped applicator is retracted 
(PROCEDURE Steps 73). The imaging well has been glued to the top of the headpost (black 
arrows) using cyanoacrylate. For imaging during visual stimulus presentation, the imaging 
well and C&B Metabond is coated with a low profile layer of black dental acrylic for light 
blocking purposes (gray arrows; PROCEDURE Steps 74-75).
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Figure 8. Cranial window removal and cleaning
(a) Top: image of the same mouse as in Figs. 3-7, 77 days after initial window implant. The 
mouse is anesthetized and secured in the headpost clamps prior to cranial window removal 
and local removal of skull regrowth and thickened dura. Note that the surgical rig has been 
covered with a sterile drape to protect the stereotax from debris created from drilling 
through dental cement. Bottom: zoomed-in view of the imaging well and cranial window as 
they appear through the surgical microscope. (b) Zoom-in of blue box region in a. The white 
arrow indicates the outer edge of the 5 mm diameter cranial window. (c) Zoomed-in view of 
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the green box in b, comparing healthy brain tissue (left of dotted black line) to an area of 
bone-growth (semi-opaque appearance to the right of dotted black outline). (d) Image of the 
cranial window after the black dental cement (see a,b) has been drilled away from the inside 
of the imaging well (OPTION A, Step vi). The white arrow points to the edge (white 
circular outline, 5 mm diameter) of the portion of the window resting on the brain. The 
orange arrow indicates the edge of the top layer of coverglass (8 mm diameter orange 
circle), whose outer 1.5 mm annulus is resting on the skull; note that all dental cement has 
been cleared from the top surface of this outer annulus. (e) Image of the cranial window as 
the outer annulus of the top coverglass is being drilled away using an FG4 carbide and a pair 
of #5/45 forceps. This procedure allows the inner glass ‘plug’ to temporarily remain in 
place, thus maintaining the integrity and cleanliness of the craniotomy (OPTION A, Step 
vii). The white arrow indicates the edge (white outline) of the inner plug, and the orange 
arrow and line outline the remaining perimeter of the top coverglass; note that the white 
C&B Metabond in d (previously beneath the top coverglass annulus) has been drilled away, 
and the underlying skull has been adequately and evenly thinned (OPTION A, Step viii). (f) 
Image of the brain after the well has been cleared of debris from drilling (OPTION A, Step 
vix), followed by removal of the cranial window plug (OPTION A, Step x). The white arrow 
indicates a Bonn micro probe being used to pierce through the dura and pry the bone growth 
(dotted-black line) from the surface of the brain (OPTION B, Step ii). (g) An image of the 
brain after removal of the bone-growth and most of the dura. White arrow indicates the dura 
as it is being removed by gentle circumferential tugging near the craniotomy margin 
(OPTION B, Step i). The black arrow indicates the transverse sinus, and the water drop 
(bottom right corner) indicates that the brain is submerged in sterile saline. (h) Image of the 
brain after the cleaning procedure (durotomy and bone-growth removal) has been performed 
and a new, 5 mm cranial window has been implanted (OPTION B, Step v). All scale bars 
are 1 mm.
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Figure 9. Targeted GCaMP3 expression and subcellular imaging in awake mice
(a) To target injections and find boundaries in the weeks or months after initial window 
implant, we first obtained images of changes in intrinsic autofluorescence in response to 
visual stimuli placed at three different positions within the visual field (darker region = 
stronger visual response; Upper scalebar inset: percent change in fluorescence). For this 
mouse, mapping occurred 65 days after initial window implant and 2 days prior to AAV-
GCaMP3 injection and window replacement. Colored circles mark the center of the 
activated region in each visual cortical area: V1 (purple), LM (green), AL (red), RL (pink), 
AM (dark blue), and PM (light blue). Lower insets: relative position of three visual stimuli 
(40° diameter, square-wave drifting grating). Note that as the visual stimulus moves towards 
lateral visual field (bottom panel), the regions of activation become further apart. (b) Raw 
fluorescence image from the experiment in a. Circles are from positions marked in a: 1st and 
3rd positions are closed circles, 2nd position is an open circle. Arrows indicate direction of 
retinotopic organization from nasal to temporal visual space. (c) Raw fluorescence image 
from same mouse as in a, 15 days after window removal and injection of AAV-GCaMP3 
targeted to within area V1. Locations of each brain area are labeled using vasculature 
landmarks from b. Scale bars in a-c: 500 μm. (d) Pixel-based map of the stimulus location 
that evoked the strongest GCaMP3 response (see inset for position color code; 25° diameter, 
square-wave drifting grating). Map brightness is scaled to maximum evoked response 
strength. Note the lack of reversals of retinotopy suggesting that the injection was contained 
entirely within V1. Same imaging session as in c. (e) Left, in vivo image of visual cortex. V1 
was covered to prevent saturation and inset was taken with lower illumination. Middle and 
right, average change in fluorescence (ΔF/F; 24 trials) of V1 axons arriving in area PM, in 
response to two different visual stimuli. Imaging depth: 90 μm. Inset: schematic of visual 
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stimuli. Scale bar: 500 and 50 μm. (f) Left, maximum projection of all single condition 
responses. Middle, expansion of maximum projection. Right, identification of significantly 
responsive boutons. Scale bar: 50 and 15 μm. (g) Average visual response timecourses of the 
colored boutons from f. Shaded regions are ± SEM; blue lines represent duration of stimulus 
(5 s; 24 repetitions per stimulus type). Data in e-g were obtained 28 days after AAV-
GCaMP3 injection and window replacement. Adapted from ref. 14. Experiments were 
approved by the IACUC at HMS.
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Figure 10. Long-term clarity of cranial windows and window replacements
Left and right pairs of columns illustrate timeline (gray vertical line), in days following 
initial window implant, through cranial window removal and AAV expression of GCaMP6, 
in two example adult mice. Green dots: sites of 100 nl injection of 
AAV.syn.GCaMP6f.WPRE.SV40. Top row: brightfield images prior to (left) and following 
(right) cranial window removal and AAV-GCaMP6 injection. Both surgeries occurred 34 
days after initial window implant. Bottom three rows: brightfield (left) and blue-green 
epifluorescence (right; all exposure times: 0.5 s) images illustrate window clarity and 
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emergence of GCaMP6 expression across months. Scalebar: 1 mm. Experiments were 
approved by the IACUC at BIDMC.
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Figure 11. Chronic functional imaging across cortical layers using a microprism
Illustration of laser beam path through a prism implanted into neocortex. The reflective 
hypotenuse of the prism converts the horizontal imaging plane into a vertical plane. (b) Left: 
Widefield epifluorescence image of a 1 mm prism implanted in visual cortex, focused 1 mm 
below the cortical surface. Fluorescent expression of AAV-GCaMP3 can be seen through 
the cranial window (green arrow), and through the prism. Right: Two-photon image taken 
through the same prism (maximum intensity projection across 15 minutes of recording) at 
205 μm lateral to the microprism imaging face, 21 days after prism implant. In this same 
mouse, cellular responses to visual stimuli varying in location, orientation, and temporal and 
spatial frequency were then imaged simultaneously across all cortical layers of mouse area 
V1 through a microprism. Scale, 1 mm (left) and 100 μm (right). (c) Maximum intensity 
projection of fractional change in GCaMP3 fluorescence (ΔF/F), computed across a stack of 
average single-condition visual response maps for each of 96 stimulus conditions. Data were 
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collected 23 days after prism implant, 180 μm from the prism face. Visually responsive 
neurons (white spots) were evident in all cortical layers. Scale, 100 μm. (d) Left: These data 
were used to generate orientation preference maps across cortical layers. Right: Neurons 
across all layers (numbered in blue in c) showed sharp orientation tuning that was consistent 
at days 21 and 23 following prism implant. Orientation tuning curves are averaged across 
stimulus locations, spatial and temporal frequencies, and normalized by peak response. 
Colored lines and colored inset in polar plots indicate estimates of orientation preference. 
These five neurons had strong responses in both sessions, exceeding 30% ΔF/F for the 
preferred orientation. (e) Chronic microprism imaging also enabled functional imaging of 
long-range axonal boutons in deeper cortical layers. To image long-range cortico-cortical 
axonal arbors in awake mice through a prism (see ref. 15), AAV-GCaMP3 was injected into 
area V1 and a microprism was subsequently inserted at the site of V1 innervation of 
posteromedial secondary visual area PM (cf. Fig. 9e). Robust visually evoked activity was 
observed in V1 axonal boutons innervating deeper layers of area PM (480-510 μm below the 
cortical surface; 1 day post-implant). (f) Left: Maximum-intensity projection of average 
single-condition response maps to upwards drifting stimuli varying in spatial and temporal 
frequency. Active boutons appear as white spots. Scale, 20 μm. Right: Time courses of three 
individual active boutons (see arrows in left panel) demonstrated robust single-trial 
responses to visual stimulation (gray bars), no fluorescence cross-talk, and little 
photobleaching (not shown). These data were adapted from ref. 15. Experiments were 
approved by the IACUC at HMS.
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Table 1
Troubleshooting table.
Step Problem Possible Reason Solution
12 Abnormal breathing The body of the mouse is not 
properly positioned or supported
Reposition mouse by raising or lowering body and 
heating pad
39 Abnormal breathing The skull has been rotated too much 
and the left (ipsilateral) ear bar is 
obstructing airflow through the 
trachea
Reposition the head so that the left ear bar makes 
contact with solid skull
45 Bottom jaw of one (or both) 
of the Altos clamps does not 
line up with the headpost
There is a height difference 
between the two altos clamps
Recalibrate alignment of headpost clamps (see 
Surgical Equipment Setup & Supplementary Fig. 
2e)
45 Headpost detaches from the 
skull when the Altos clamps 
are tightened
There is a rotational difference 
between the two headpost clamps
Recalibrate alignment of headpost clamps (see 
Surgical Equipment Setup & Supplementary Fig. 
2e)
46 The nose-cone shield does 
not cover the snout
There is a substantial degree of tilt 
in the headpost implant
Adjust the height, level of rotation, and/or level of 
elevation in the mouse anesthesia gas head
52 Drilling away the cement has 
resulted in bleeding of the 
underlying muscle
The drill bit has severed underlying 
muscle tissue that was not properly 
treated with Vetbond in Step 25
Irrigate with sterile saline and reapply Vetbond
54, 56 Subdural bleeding occurs 
when thinning the skull
Overheating due to drilling for too 
long or at high speed without 
intermittent sterile saline rinse
Continue only if bleeding is minor or localized (see 
also Caution Statements in Step 54)
Skull has been thinned down too 
much
No solution; next time, drill slower and irrigate 
more frequently
58 Blood emerges from the site 
of drilling
A blood vessel was punctured Irrigate with sterile saline until bleeding stops
A sinus was punctured Irrigate with sterile saline until bleeding stops; if 
bleeding persists apply gel foam to sinus and 
continue to irrigate until bleeding stops
58 Dura is torn The drill bit punctured the dura 
when drilling the craniotomy
Perform a durotomy only if the dura has been torn 
over the area to be imaged, otherwise proceed as 
usual; if brain or vasculature appears damaged, 
terminate surgery
58 Dura is torn and excessive 
bleeding occurs
The dura was pulled with too much 
tension over an area with an 
underlying sinus
Apply gel foam immediately followed by light 
irrigation of sterile saline (while the gel foam rests 
on the affected area). Expect fatality rates to exceed 
50%. Success rates can occasionally be improved 
by proceeding with the cranial window implant 
promptly after the sinus has be torn (as the pressure 
from the cranial window can prevent sinusoidal 
blood loss). In such cases, thicker dura and/or bone 
growth underneath the cranial window may result, 
thus requiring additional subsequent procedures to 
improve optical clarity
58 Subdural bleeding A cortical blood vessel has been 
pierced or has ruptured due to 
excessive pressure buildup in the 
brain
Perform a durotomy (OPTION B). If successful 
(cortical vasculature is intact edema is minimal, and 
bleeding is controlled), start at Step 50. Otherwise, 
terminate surgery
58 Bleeding occurs upon 
removal of the bone flap
A blood vessel has been ripped or 
punctured
Irrigate with sterile saline until bleeding stops; if 
bleeding persists, apply gel foam and continue to 
irrigate until bleeding stops
A sinus has be ripped or punctured Apply gel foam and continue to irrigate until 
bleeding stops. If excessive bleeding occurs, the 
surgery may result in fatality
58 Excessive edema upon 
removal of the bone flap
Rough drilling No solution; refine motor skills and be more 
delicate to avoid drilling past the skull in future
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Step Problem Possible Reason Solution
Dexamethasone was not 
administered early enough prior to 
surgery
No solution; wait at least 4 hours after 
administration, prior to surgery
59 Cortical edema occurs after 
performing a craniotomy
The craniotomy is too large (ie. >3 
mm) and is positioned too far 
laterally from the midline
If possible, use a 3 mm cranial window
66 The cranial window does not 
fit into the craniotomy
The craniotomy is too small Remove the cranial window and try to expand the 
craniotomy using a micro probe (angled 45°). 
Expect lower success rates
Excessive amount of optical glue 
was used during fabrication and has 
resulted in overflow–making the 
cranial window too large to fit
This can be avoided by evaluating the quality and 
size of cranial windows prior to surgical use
67 The cranial window breaks Too much pressure was applied to 
the window by the fashioned 
cotton-tipped applicator
Terminate surgery, as the underlying brain will 
likely be damaged
The skull margins surrounding the 
craniotomy were not thinned 
consistently or sufficiently
No solution; terminate surgery. Next time, allow the 
skull to soak in saline and probe for pliability 
around the skull margins
67 The different layers of the 
cranial window become 
separated
The cranial window was not 
properly glued together, likely due 
to too little optical glue
Evaluate cranial windows under the surgical scope 
prior to use. Lack of optical glue will result in air 
spaces or bubbles between the coverglasses. In this 
case, or if overflow of excessive optical glue is 
observed, discard window
69 Fluid wicking leads to air 
space in one or more portions 
of the interface between 
cranial window and brain 
surface
Inadequate pressure applied to the 
brain surface prior to wicking
Slightly reduce the vertical pressure being applied 
by the micromanipulator and add more sterile saline 
to fill any air spaces between the brain and the 
cranial window. Reapply pressure, and remove 
saline until the bone is dry, but avoid removal from 
beneath the portion of the cranial window resting 
on the skull
The skull margins surrounding the 
craniotomy were not thinned 
consistently or sufficiently and 
therefore are preventing both 
adequate pressure and uniform 
contact between the brain and the 
cranial window
No solution; this will likely result in thickening of 
the dura and/or bone regrowth. It is likely that a 
follow up surgery will be required to fix this 
problem
70 Vetbond overflows and 
attaches the cotton-tipped 
applicator to the cranial 
window
Excessive pressure was applied 
through the spout of the Vetbond 
applicator
See ‘CAUTION’ in PROCEDURE Step 71
70 Vetbond comes in contact 
with the brain surface
Not enough pressure was applied to 
applicator
No solution, terminate surgery
Bone has not been thinned 
uniformly and/or sufficiently
No solution, terminate surgery
OPTION A, 
Step vii
The center portion of the 
cranial window (the part 
resting on the brain) has 
become loose (i.e. is not snug 
within the craniotomy)
Irrigation must be performed to remove any debris 
remaining in the headpost well prior to removal of 
the plug
OPTION A, 
Step vii
Bleeding has resulted 
underneath the center portion 
of the cranial window (the 
part resting on the brain)
Drilling away the top layer of the 
cranial window resting on the skull 
has aggravated underlying 
vasculature, resulting in a bleed
If bleed is minimal and does not obstruct viewing of 
the surgical site, continue to drill off the top layer 
and complete thinning the surrounding skull; if not, 
terminate surgery
Excessive force on applicator 
caused the window to buckle
No solution, terminate surgery
OPTION B, 
Step iv
Cortical vascular is removed 
from the brain upon removal 
of the dura
If this occurs on the same day that 
the craniotomy has been performed, 
No solution; refine motor skills and be more 
delicate. Terminate surgery
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Step Problem Possible Reason Solution
then it is likely to be a result of 
human error
If this occurs on a separate day after 
the brain has already been exposed 
via craniotomy, then it is likely that 
the first craniotomy has resulted in 
cortical scarring and adhesion to the 
dura
No solution; terminate surgery
OPTION B, 
Step iv
A sinus is punctured while 
performing the durotomy
The dura was pulled with too much 
tension over an area with an 
underlying sinus
Try to control any bleeding by applying gel foam, 
then lightly irrigate with sterile saline as the gel 
foam rests over the punctured sinus. If bleeding 
persists, terminate surgery
OPTION C, 
Step xii
The microprism assembly 
doesn't line up with the 
incision
Human error; line of incision in 
brain or positioning of microprism 
on cranial window was imprecise
No solution; terminate surgery
General 
problem 
related to 
intracerebral 
injections
An air bubble is observed 
inside the micropipette
Human error; the Hamilton syringe 
was not loaded correctly
Re-load injection syringe
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